# Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease

> **NCT01693081** · PHASE2 · COMPLETED · sponsor: **South Glasgow University Hospitals NHS Trust** · enrollment: 47 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** VR040/Aspirair® inhaler
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01693081
- **Lead sponsor:** South Glasgow University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-07
- **Final completion:** 2009-07
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2012-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01693081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01693081, "Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01693081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*